8th Annual MarketsandMarkets

High Potent Medicines Conference

24th - 26th May 2023

Duo Milan Porta Nuova, Via Gerolamo Cardano, 1, 20124 Milano MI, Italy.

Looking and the current market scenario, many companies are outsourcing the manufacture of their highly potent compounds for various reasons, mainly marketing. The escalation in the High Potent drug market is subjected to a variety of aspects such as the diversification of pharmaceutical manufacturers towards precision medicines such as HPAPI, increasing demand for oncology drugs & antibody-drug conjugates, and advancements in HPAPI manufacturing technologies.
 

We are delighted to announce our 8th Annual MarketsandMarkets High Potent Medicines Conference, scheduled to be on 24th -26th May 2023, in Italy. This conference will evidence the presence of some great minds in the Medical and Pharmaceutical industry bringing you the solutions to the challenges faced in advanced High Potent Medicines. Grab the opportunity to interact with them, 10+ hours of dedicated networking for two days in a row and meet your potential targets to create target revenue.

WHAT TO EXPECT

  • Process Development and scale up of HPAPI’s
  • Strategies for effective outsourcing partnership
  • Containment and Handling Strategies
  • Validation of cleaning procedures to avoid cross contamination
  • Regulatory Landscape
  • Hazard Assessment Classifications

  • Utilizing the best practices to ensure safe and efficient production of high potent medicines
  • Training sessions on complex high potent compounds handling and containment issues
  • Understanding the updated regulatory guidelines in the HPAPI process
  • Implementing response plans to react to an unplanned event
  • Knowing the outsourcing strategies to effectively build a reliable supply chain

From pharmaceutical and Biopharmaceutical manufacturing:

Chief executives, VP’s, Directors, Heads, Leaders, Senior Managers, Principal Scientists, Principal Toxicologists, Toxicologists, Fellows, Investigators working in:

  • Research & Development
  • Manufacturing/Operations/Production
  • Maintenance
  • Engineering
  • Risk Assessments
  • Laboratory Services/Analytical
  • New Technologies
  • Process Development/Technical transfer

CONFERENCE AGENDA

Registration

08:15 - 09:00

Welcome note from MarketsandMarkets

09:00 - 09:05

Opening Remarks from the Chairman

Dean Calhoun

Dean Calhoun , President, CEO, Affygility Soultions, USA

09:05 - 09:10

Keynote Presentation: Revolutionizing Pharmaceutical Manufacturing: Harnessing the Power of Artificial Intelligence and In Silico Tools

Dean Calhoun

Dean Calhoun , President, CEO, Affygility Soultions, USA

09:10 - 09:40

Process Development and Scale up

Cryogenic Milling and cleaning Processes under GMP conditions

Hermann Schmidt

Hermann Schmidt, Operations Director, Pharma & Lab Division, Hosokawa Alpine AG

09:40 - 10:10

Morning Refreshments and Poster Presentation | One-to-One Networking Meetings

10:10 - 11:00

From lab to commercial production -How to combat challenges in OSD High potency products development

Carolina Bonifacio

Carolina Bonifacio, Siegfried, Head, Drug Product Development

11:00 - 11:30

High Containment Kilolab Plant: From Design to Process Validation

Helena Camps

Helena Camps, R&D Director, MOEHS Fine Chemicals

11:30 - 12:00

Outsourcing High Potent OSD Late Stage Development: CDMO Insights

David O’Connell

David O’Connell, Director, Scientific Affairs, PCI Pharma Services, UK

12:00 - 12:30

Manufacturing of Oncological Products by a CDMO

Fabio Zenobi

Fabio Zenobi, EHS Director, BSP Pharmaceuticals, Italy

12:30 - 13:00

Lunch and Poster Presentation | One-to-One Networking Meetings

13:00 - 14:00

Containment and Handling

Efficient Handling of high-potent APIs – a CDMO perspective

Martina Breuer

Martina Breuer, Head, Operations, Aenova Group

14:00 - 14:30

Large Scale HPAPI Micronization

Andrew Lemaire

Andrew Lemaire, Global Director Containment & Micronization, DEC Group

14:30 - 15:05

HPAPI Milling and Micronization contained system

Stefano Butti

Stefano Butti , Sales Director, FPS

15:00 - 15:30

Afternoon Refreshments and Poster Presentation | One-to-One Networking Meetings

15:30 - 16:15

Engineering of containment in a OEB5 facility

Pietro Virgilio

Pietro Virgilio , Process Design Containment, Exyte, Italy

16:15 - 16:45

Verification and Monitoring of Containment Performance

Tara Dennis

Tara Dennis, Occupational Hygiene Manager, SafeBridge

16:45 - 17:05

Closing Remarks from the Chairman

Dean Calhoun

Dean Calhoun , President, CEO, Affygility Soultions, USA

17:05 - 17:10

Drinks Reception & Networking

17:10 - 17:10

End of Day 1

17:10 - 17:10

Registration

08:15 - 09:00

Welcome note from MarketsandMarkets

09:00 - 09:05

Opening Remarks from the Chairman

Dean Calhoun

Dean Calhoun , President, CEO, Affygility Soultions, USA

09:05 - 09:10

Keynote Presentation: Strategic Elements within HPAPI Projects

Justin Mason-Home

Justin Mason-Home, Director, HPAPI Services

09:10 - 09:40

Containment and Handling

Technology transfer – more than a check list

Anna Kulesza

Anna Kulesza, Director, Pharmaceutical Development, Clovis Oncology

09:40 - 10:10

Morning Refreshments and Poster Presentation | One-to-One Networking Meeting

10:10 - 11:00

CMO selection and partnership

Filippo Saleri

Filippo Saleri, Subject Matter Expert CMO, Ferring Pharmaceuticals

11:00 - 11:30

Isolator Technology – the most proper solution for HPAPI handling

Marco Alberio

Marco Alberio, Engineering Director, Pharmaprocess

11:30 - 12:00

Potent European regulation requests about high containment

Giorgio Mari

Giorgio Mari, Senior Process Engineer, Exyte

12:00 - 12:30

Campoverde: an Abbvie plant for containment production

Giorgia Scoppa

Giorgia Scoppa, NPI Program Manager, AbbVie

12:30 - 13:00

Cleaning Validation and Risk Mitigation

Lunch and Poster Presentation | One-to-One Networking Meetings

13:00 - 14:00

Sources of uncertainty in toxicological risk assessment

Martin Kohan

Martin Kohan, Senior Occupational Toxicologist, SafeBridge

14:00 - 14:30

Cleaning Validation for shared equipment in manufacturing of highly potent APIs

Stefania Vergura

Stefania Vergura, Validation Expert, Novartis

14:30 - 15:00

Closing remarks from the Chairman

Dean Calhoun

Dean Calhoun , President, CEO, Affygility Soultions, USA

15:00 - 15:05

End of Conference

15:05 - 15:05

Transfer from Hotel to FPS factory

08:00 - 10:00

Registration and coffee break

10:00 - 10:15

Welcome introduction

10:15 - 10:30

SESSION 1: Process equipment integration into containment systems

10:30 - 11:15

Q&A

11:15 - 11:30

SESSION 2: Containment performance verification

11:30 - 12:15

Q&A

12:15 - 12:30

Lunch break / buffet

12:30 - 14:00

SESSION 3: Guided Company Tour

14:00 - 15:00

SESSION 4: LIVE DEMO - Q&A

Shailendra Singh (Shelly)

Shailendra Singh (Shelly), Board Member, MarketsandMarkets

15:00 - 16:00

Final notes

16:00 - 16:15

Transfer from Hotel / Linate Airport

16:15 - 16:15

SPEAKERS

Pietro Virgilio

Pietro Virgilio

Process Design Containment, Exyte, Italy

Giorgio Mari

Giorgio Mari

Senior Process Engineer, Exyte

Stefano Butti

Stefano Butti

Sales Director, FPS

Justin Mason-Home

Justin Mason-Home

Director, HPAPI Services

Dean Calhoun

Dean Calhoun

President, CEO, Affygility Soultions, USA

Andrew Lemaire

Andrew Lemaire

Global Director Containment & Micronization, DEC Group

Carolina Bonifacio

Carolina Bonifacio

Siegfried, Head, Drug Product Development

Hermann Schmidt

Hermann Schmidt

Operations Director, Pharma & Lab Division, Hosokawa Alpine AG

Fabio Zenobi

Fabio Zenobi

EHS Director, BSP Pharmaceuticals, Italy

Martina Breuer

Martina Breuer

Head, Operations, Aenova Group

Martin Kohan

Martin Kohan

Senior Occupational Toxicologist, SafeBridge

Tara Dennis

Tara Dennis

Occupational Hygiene Manager, SafeBridge

Helena Camps

Helena Camps

R&D Director, MOEHS Fine Chemicals

Ronnie Miranda

Ronnie Miranda

Process Chemist, MOEHS Fine Chemicals

Stefania Vergura

Stefania Vergura

Validation Expert, Novartis

Filippo Saleri

Filippo Saleri

Subject Matter Expert CMO, Ferring Pharmaceuticals

Marco Alberio

Marco Alberio

Engineering Director, Pharmaprocess

Anna Kulesza

Anna Kulesza

Director, Pharmaceutical Development, Clovis Oncology

Giorgia Scoppa

Giorgia Scoppa

NPI Program Manager, AbbVie

Salvatore Sorrentino

Salvatore Sorrentino

EHS & LPA Supervisor, AbbVie

David O’Connell

David O’Connell

Director, Scientific Affairs, PCI Pharma Services, UK

ENQUIRE NOW

SPONSORS

PARTNERS

LOCATION

Venue

Duo Milan Porta Nuova, Via Gerolamo Cardano, 1, 20124 Milano MI, Italy.

PAST EVENT GALLERY